During the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Washington D.C. on March 13th 2019, the Pharmacogenomics Research Network (PGRN) presented a Trainee Abstract Award to U-PGx’s Cathelijne van der Wouden. Within U-PGx Cathelijne is working as a PhD student and coordinating researcher for the PREPARE study. She was presented this award for her work regarding the IP3 study, a pilot study for the PREPARE study, where she reported on the real-world impact of implementing pharmacist-initiated pre-emptive pharmacogenetic testing with clinical decision support into primary care in the Netherlands.
